- £185.83bn
- £207.08bn
- $45.81bn
- 80
- 12
- 96
- 70
REG - AstraZeneca PLC - Alexion enters gene therapy agreement with Pfizer
AnnouncementREG - AstraZeneca PLC - Half-year Report
AnnouncementREG - AstraZeneca PLC - Beyfortus approved in US for infant RSV prevention
AnnouncementREG - AstraZeneca PLC - Total Voting Rights
AnnouncementREG - AstraZeneca PLC - Dato-DXd significantly improved PFS in lung cancer
AnnouncementREG - AstraZeneca PLC - nirsevimab recommended for infant RSV protection
AnnouncementREG - AstraZeneca PLC - AstraZeneca agreement with Quell Therapeutics
AnnouncementREG - AstraZeneca PLC - Imfinzi improved pCR in gastric and GEJ cancers
AnnouncementREG - AstraZeneca PLC - Block listing Interim Review
AnnouncementREG - AstraZeneca PLC - Total Voting Rights
AnnouncementREG - AstraZeneca PLC - Lynparza approved in US for BRCAm prostate cancer
AnnouncementREG - AstraZeneca PLC - Imfinzi + Lynparza prolonged PFS in endometrial ca
AnnouncementRCS - Neurimmune - Neurimmune: Promising NI006 Phase1 Results in NEJM
AnnouncementREG - AstraZeneca PLC - Directorate Change
AnnouncementREG - AstraZeneca PLC - Tagrisso plus chemo improved PFS in lung cancer
AnnouncementREG - AstraZeneca PLC - Director/PDMR Shareholding
AnnouncementREG - AstraZeneca PLC - Farxiga extended in the US for heart failure
AnnouncementREG - AstraZeneca PLC - Total Voting Rights
AnnouncementREG - AstraZeneca PLC - Director/PDMR Shareholding
Announcement